Skip to Main Content

Author Details

Gillian Mitchell
Familial Cancer Centre Peter MacCallum Cancer Centre Parkville Victoria 0 Australia.
1998
121
40
PMIDPaper TitleJournal TitlePublished Year
36618023The Risk-Reducing Effect of Aspirin in Lynch Syndrome Carriers: Development and Evaluation of an Educational Leaflet.Adv Genet (Hoboken)2022
36618023The Risk-Reducing Effect of Aspirin in Lynch Syndrome Carriers: Development and Evaluation of an Educational Leaflet.Adv Genet (Hoboken)2022
33168572Implementing gene curation for hereditary cancer susceptibility in Australia: achieving consensus on genes with clinical utility.J Med Genet2021
33836815Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice.Hered Cancer Clin Pract2021
33168572Implementing gene curation for hereditary cancer susceptibility in Australia: achieving consensus on genes with clinical utility.J Med Genet2021
33836815Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice.Hered Cancer Clin Pract2021
31595523The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome.Med J Aust2020
31595523The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome.Med J Aust2020
31996782Cost-effectiveness of long-term clinical management of BRCA pathogenic variant carriers.Genet Med2020
32565470Pathways to a cancer-free future: a protocol for modelled evaluations to minimise the future burden of colorectal cancer in Australia.BMJ Open2020
31996782Cost-effectiveness of long-term clinical management of BRCA pathogenic variant carriers.Genet Med2020
32565470Pathways to a cancer-free future: a protocol for modelled evaluations to minimise the future burden of colorectal cancer in Australia.BMJ Open2020
30525267Assessing the medical workforces perceived barriers to the prescription of risk-reducing medication for women at high-risk of breast cancer.Breast J2019
30525267Assessing the medical workforces perceived barriers to the prescription of risk-reducing medication for women at high-risk of breast cancer.Breast J2019
31221211Comparing theory and non-theory based implementation approaches to improving referral practices in cancer genetics: a cluster randomised trial protocol.Trials2019
31426925A Microsimulation Model for Evaluating the Effectiveness of Cancer Risk Management for BRCA Pathogenic Variant Carriers: miBRovaCAre.Value Health2019
31384883Cancer screening in Australia: future directions in melanoma, Lynch syndrome, and liver, lung and prostate cancers.Public Health Res Pract2019
31384883Cancer screening in Australia: future directions in melanoma, Lynch syndrome, and liver, lung and prostate cancers.Public Health Res Pract2019
31426925A Microsimulation Model for Evaluating the Effectiveness of Cancer Risk Management for BRCA Pathogenic Variant Carriers: miBRovaCAre.Value Health2019
31221211Comparing theory and non-theory based implementation approaches to improving referral practices in cancer genetics: a cluster randomised trial protocol.Trials2019
28822109Consumer attitudes towards the establishment of a national Australian familial cancer research database by the Inherited Cancer Connect (ICCon) Partnership.J Community Genet2018
28822109Consumer attitudes towards the establishment of a national Australian familial cancer research database by the Inherited Cancer Connect (ICCon) Partnership.J Community Genet2018
30294856Current mismatch repair deficiency tumor testing practices and capabilities: A survey of Australian pathology providers.Asia Pac J Clin Oncol2018
30005762Heterogeneity and Uncertainties Specific to Genome-Based Health Technological Assessments.Value Health2018
29168041Making Sense of SNPs: Women's Understanding and Experiences of Receiving a Personalized Profile of Their Breast Cancer Risks.J Genet Couns2018
29599518Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history.Eur J Hum Genet2018
29506471A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention.BMC Cancer2018
29323669Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review.Genet Med2018
30005762Heterogeneity and Uncertainties Specific to Genome-Based Health Technological Assessments.Value Health2018
30294856Current mismatch repair deficiency tumor testing practices and capabilities: A survey of Australian pathology providers.Asia Pac J Clin Oncol2018
29599518Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history.Eur J Hum Genet2018
29506471A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention.BMC Cancer2018
29323669Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review.Genet Med2018
29168041Making Sense of SNPs: Women's Understanding and Experiences of Receiving a Personalized Profile of Their Breast Cancer Risks.J Genet Couns2018
27171545Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab.Genet Med2017
28772290Surveillance in Germline TP53 Mutation Carriers Utilizing Whole-Body Magnetic Resonance Imaging.JAMA Oncol2017
28346442Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.Nat Genet2017
28943990Motivators and barriers of tamoxifen use as risk-reducing medication amongst women at increased breast cancer risk: a systematic literature review.Hered Cancer Clin Pract2017
28720130Psychosocial and behavioral impact of breast cancer risk assessed by testing for common risk variants: protocol of a prospective study.BMC Cancer2017
28448241Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores.J Clin Oncol2017
29058716Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.Nat Genet2017
29224207Acute kidney injury is under-recognised and under-reported in hospitalised patients in Australia.Intern Med J2017
27171545Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab.Genet Med2017
27684037Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision making about treatment-focused genetic testing: a randomized controlled noninferiority trial.Genet Med2017
27677266Exploring clinicians' attitudes about using aspirin for risk reduction in people with Lynch Syndrome with no personal diagnosis of colorectal cancer.Fam Cancer2017
28124295Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial?Fam Cancer2017
28124295Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial?Fam Cancer2017
28448241Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores.J Clin Oncol2017
28346442Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.Nat Genet2017
29058716Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.Nat Genet2017
  • 1 - 50 of 242

Recommended Authors

Padma S Rajagopal
National Cancer Institute, National Institutes of Health
Career Start Year 2014
Number of shared co-authors 2
Eloise Chapman-Davis
Weill Cornell Medical College
Career Start Year 2009
Number of shared co-authors 1
Eric C Polley
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 47
Catherine M Kelly
Mater Misericordiae University Hospital
Career Start Year 2006
Number of shared co-authors 4
Pamela J Provan
Westmead Institute for Medical Research, Westmead Hospital, The University of Sydney
Career Start Year 2006
Number of shared co-authors 19
Larissa A Korde
Clinical Investigations Branch, National Cancer Institute
Career Start Year 2004
Number of shared co-authors 13
Hisani N Horne
National Cancer Institute
Career Start Year 2004
Number of shared co-authors 31
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 6
Mary S Beattie
University of California san francisco
Career Start Year 2002
Number of shared co-authors 69
Scott M Weissman
Center for Medical Genetics, NorthShore University HealthSystem
Career Start Year 2001
Number of shared co-authors 26
Richard B Schwab
Department of Medicine and Moores Cancer Center, University of California San Diego
Career Start Year 2000
Number of shared co-authors 1
Susan C Modesitt
University of Virginia, Emily Couric Clinical Cancer Center
Career Start Year 1998
Number of shared co-authors 3
Michel Dorval
CHU de Quebec-Universite Laval Research Center
Career Start Year 1998
Number of shared co-authors 9
Sandhya Pruthi
Mayo Clinic
Career Start Year 1997
Number of shared co-authors 6
Nikolajs Zeps
Queensland University of Technology
Career Start Year 1996
Number of shared co-authors 1
Lisa Madlensky
Department of Medicine and Moores Cancer Center, University of California San Diego.
Career Start Year 1994
Number of shared co-authors 8
Rosemary L Balleine
Westmead Institute for Medical Research, The University of Sydney
Career Start Year 1993
Number of shared co-authors 100
Abenaa M Brewster
The University of Texas MD Anderson Cancer Center
Career Start Year 1993
Number of shared co-authors 8
Kevin Sweet
College of Medicine, The Ohio State University
Career Start Year 1992
Number of shared co-authors 28
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 80
Clare Turnbull
Institute of Cancer Research
Career Start Year 1991
Number of shared co-authors 87
Peggy L Porter
Fred Hutchinson Cancer Research Center
Career Start Year 1991
Number of shared co-authors 7
James M Ford
Stanford University
Career Start Year 1989
Number of shared co-authors 16
Jeffery P Struewing
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1988
Number of shared co-authors 40
Barbara L Weber
Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania
Career Start Year 1988
Number of shared co-authors 59
Georgia L Wiesner
Vanderbilt Genetics Institute, Vanderbilt University Medical Center
Career Start Year 1986
Number of shared co-authors 10
Lynn G Dressler
Duke University Research Institute
Career Start Year 1985
Number of shared co-authors 6
Craig D Shriver
Walter Reed National Military Medical Center
Career Start Year 1985
Number of shared co-authors 4
Laura J Van't Veer
University of California San Francisco
Career Start Year 1984
Number of shared co-authors 111
Kathleen I Pritchard
UCL Great Ormond Street Institute of Child Health, University College London
Career Start Year 1976
Number of shared co-authors 9

Collaborators

Rosalind A Eeles
The Institute of Cancer Research
Co-authored papers 21
Judy Kirk
Co-authored papers 21
Susan M Domchek
Co-authored papers 17
Bettina Meiser
Co-authored papers 17
Ian G Campbell
Co-authored papers 16
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 15
Douglas F Easton
University of Cambridge
Co-authored papers 14
David D L Bowtell
Peter MacCallum Cancer Centre
Co-authored papers 13
Kathryn Alsop
Peter MacCallum Cancer Centre
Co-authored papers 13
David E Goldgar
University of Utah
Co-authored papers 12
Irene L Andrulis
University of Toronto
Co-authored papers 12
Louise Izatt
Guy's and St Thomas' NHS Foundation Trust
Co-authored papers 11
Jan Lubinski
Pomeranian Medical University
Co-authored papers 11
Fergus J Couch
Mayo Clinic
Co-authored papers 11
Javier Ben??tez
Instituto de Salud Carlos III
Co-authored papers 10
Siranoush Manoukian
Fondazione IRCCS Istituto Nazionale dei Tumori
Co-authored papers 10
Esther M John
Co-authored papers 10
Judy E Garber
Dana-Farber Cancer Institute
Co-authored papers 9
Paolo Radice
Ospedale Circolo e Fondazione Macchi
Co-authored papers 9
Beth Y Karlan
David Geffen School of Medicine, University of California los angeles
Co-authored papers 9
Katherine L Nathanson
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Co-authored papers 8
Heather Thorne
Peter MacCallum Cancer Centre
Co-authored papers 8
Mandy L Ballinger
Garvan Institute of Medical Research
Co-authored papers 8
Mary Beth Terry
Co-authored papers 8
David M Thomas
Garvan Institute of Medical Research
Co-authored papers 8
Robert L Nussbaum
Invitae Corporation
Co-authored papers 8
Jenny Lester
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers 8
Amanda B Spurdle
QIMR Berghofer Medical Research Institute
Co-authored papers 8
Ana Osorio
Familial Cancer Clinical Unit, Spanish National Cancer Research Centre
Co-authored papers 8
Claudine Isaacs
Co-authored papers 7
Release 1.2